Fri 25'th May 2018
Iovance Biotherapeutics, Inc. Stock Analysis
Technical stock analysis for Fri 25'th May 2018
Iovance Biotherapeutics, Inc. fell by -3.63% in the last day from $16.55 to $15.95 The price has been going up and down for this period, and there has been a 4.93% gain for the last 2 weeks. Volume has increased in the last day by 45 691 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 377 302 shares bought and sold for approximately $6.02 million.
|Shorts||7.71% ( 2018-04-30 )|
Iovance Biotherapeutics, Inc. lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $16.70 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -16.12% during the next 3 months and, with 90% probability hold a price between $10.12 and $14.00 at the end of this period.
There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Friday May 18, 2018, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Iovance Biotherapeutics, Inc. holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $16.44. On a fall, the stock will find some support from the long-term average at approximately $15.26. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.
Relative Strength Index (RSI)
RSI14 is 57 and the stock is currently not being overbought or oversold
Support & Resistance
Iovance Biotherapeutics, Inc. finds support from accumulated volume at $15.25.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.85 between high and low, or 5.40%. For the last week, the stock has had a daily average volatility of 4.48%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Iovance Biotherapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.
Trade IOVA CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).
Access these features
Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder